Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells

Inflammation Research

Volumn 48, Issue 5, 1999, Pages 274-279

  Okada, T ^a   Hirayama, Y ^a   Kishi, S ^a   Miyayasu, K ^a   Hiroi, J ^a   Fujii, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Histamine release; Mast cell; NK 1 receptor; Substance P

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; HISTAMINE; IODINE 125; MESSENGER RNA; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; SUBSTANCE P; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; HISTAMINE RELEASE; MALE; NONHUMAN; PERITONEUM MAST CELL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; HISTAMINE RELEASE; MALE; MAST CELLS; PERITONEAL CAVITY; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, NEUROKININ-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE P; SUCCINIMIDES;

EID: 0033057786     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050459     Document Type: Article

References (28)

1. [1] Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P related peptides. Pharmacol Rev 1994; 46: 551-99.
2. [2] Alving K, Sundstrom C, Matran R, Panula P, Hokfelt T, Lundberg JM. Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs. Cell Tissue Res 1991; 264: 529-38.
3. [3] Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987; 84: 2975-9.
4. [4] Dimitriadou V, Rouleau A, Trung Tuong MD, Newlands GJF, Miller HRP, Luffau G, et al. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience 1997; 77: 829-39.
5. [5] Johnson AR, Erdös EG. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 1973; 142: 1252-6.
6. [6] Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM. Purification and characterization of human mast cells: Evidence for human mast cell heterogeneity. J Immunol 1987; 139: 3062-9.
7. [7] Repke H, Bienert M. Structural requirements for mast cell triggering by substance P-like peptides. Agents Actions 1988; 23: 207-10.
8. [8] Devillier P, Drapeau G, Renoux M, Regoli D. Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. Eur J Pharmacol 1989; 168: 53-60.
9. [9] Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 1996; 81: 68-73.
10. [10] Krumins SA, Broomfield CA. Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in murine mast cell line. Neuropeptides 1992; 21: 65-72.
11. [11] Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-α gene expression in murine mast cells. J Immunol 1993; 150: 4478-85.
12. [12] Joos GF, Kips JC, Pauwels RA. In vivo characterization of the tachykinin receptors involved in the direct and indirect broncho-constrictor effect of tachykinins in two inbred rat strains. Am J Respir Crit Care Med 1994; 149: 1160-6.
13. [13] Germonpre PR, Joos GF, Everaert ELS, Kips JC, Pauwels RA. Characterization of neurogenic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care Med 1995; 152: 1796-804.
14. [14] Lilly CM, Hall AE, Rodger IW, Kobzik L, Haley KJ, Drazen JM. Substance P-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol 1995; 78: 1234-41.
15. [15] Wang L, Stanisz AM, Wershil BK, Galli SJ, Perdue MR. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am J Physiol 1995; 269: G85-92.
16. [16] Ottosson A, Edvinsson L. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 1997; 17: 166-74.
17. [17] Ogawa K, Kohno S, Nabe T, Yamamura H, Ohata K. High response of peritoneal mast cells from a substrain of Wistar (Std) rats to neuropeptides with histamine release. Jpn J Pharmacol 1994; 64 (Suppl 1): 64.
18. [18] Shore PA, Burkhalter A, Cohn VH. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959; 127: 182-6.
19. [19] Gilchrist M, McDonald AJ, Neverova I, Ritchie B, Befus AD. Optimization of the isolation and effective use of mRNA from rat mast cells. J Immunol Methods 1997; 201: 207-14.
20. [20] McPherson GA. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods 1985; 14: 213-28.
21. [21] Munson PJ, Rodbard D. A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-39.
22. [22] Hagan RM, Ireland SJ, Jordan CC, Bereford IJM, Deal MJ, Ward P. Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides 1991; 19: 127-35.
23. [23] Drapeau G, D'Orleans-Juste P, Dion S, Rhaleb NE, Roussi D, Regoli D. Selective agonists for neurokinin receptors. Neuropeptides 1987; 10: 43-54.
24. [24] Fujii T, Murai M, Morimoto H, Maeda Y, Yamaoka M, Hagiwara D, et al. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist. Br J Pharmacol 1992; 107: 785-9.
25. [25] McLean S, Ganong A, Seymour PA, Sider RM, Desai MC, Osen T, et al. Pharmacology of CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor. J Pharmacol Exp Ther 1993; 267: 472-9.
26. 2) receptor. Life Sci 1992; 50: PL101-6.
27. 1 receptors on a mucosal-like mast cell line, RBL-2H3 cells. Can J Physiol Pharmacol 1998; 76: 188-93.
28. [28] Maggi CA. The effect of tachykinins on inflammatory and immune cells. Regul Pept 1997; 70: 75-90.